Orris

Discuss the metabolism of bilirubin and types of jaundice

Reading File
Finding Sources
Finding Sources
Searching PubMed

bilirubin metabolism jaundice

Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
Reading File
Loading Image
Reading File
Reading File
I now have all the information needed for a comprehensive, well-cited response. Let me compile the full answer.

Bilirubin Metabolism and Types of Jaundice

1. Overview of Bilirubin

Bilirubin is the end product of heme catabolism. Approximately 70-90% is derived from the degradation of hemoglobin in senescent red blood cells; the remainder comes from myoglobin, cytochromes, and ineffective erythropoiesis. Normal total plasma bilirubin is <1 mg/dL, with the unconjugated fraction comprising the majority. - Harrison's Principles of Internal Medicine, 22E

2. Bilirubin Production: Heme to Bilirubin

Conversion of heme to bilirubin via heme oxygenase and biliverdin reductase
Fig. 28-5 from Ganong's Review of Medical Physiology: Two-step conversion of heme to bilirubin.
The breakdown occurs in two enzymatic steps:
  1. Heme oxygenase opens the porphyrin ring of heme, using NADPH + O₂, releasing CO, Fe³⁺, and the green pigment biliverdin (IXα).
  2. Biliverdin reductase reduces biliverdin to the yellow-orange bilirubin (IXα), consuming NADPH.
Unconjugated (free) bilirubin is water-insoluble and is held in its conformation by internal hydrogen bonding. It is potentially toxic (especially to neurons) and must be transported and conjugated before excretion. - Ganong's Review of Medical Physiology, 26th Ed.

3. Transport in the Blood

Unconjugated bilirubin (UCB) is tightly bound to serum albumin for transport in the circulation. This binding prevents glomerular filtration - therefore, unconjugated bilirubin does not appear in the urine. It traverses endothelial fenestrae to reach the hepatocyte surface (Space of Disse). - Harrison's 22E

4. Hepatic Processing: Four Key Steps

Hepatocellular bilirubin transport diagram - OATP, GST, UGT1A1, MRP2, MRP3 transporters
Hepatocellular bilirubin transport (Harrison's 22E, Fig. 349-1)

Step 1 - Hepatocellular Uptake

UCB dissociates from albumin and is taken up into hepatocytes via organic anion transporting polypeptides (OATPs) - particularly OATP1B1 and OATP1B3. The identity of the primary bilirubin transporter remains incompletely defined. Certain drugs (rifampicin, flavaspidic acid, novobiocin, cholecystographic contrast agents) can competitively inhibit this uptake. - Harrison's 22E

Step 2 - Intracellular Binding

Inside the hepatocyte, UCB is kept in solution by binding as a non-substrate ligand to glutathione-S-transferases (GSTs), formerly called ligandins. This prevents back-diffusion into the sinusoid. - Harrison's 22E

Step 3 - Conjugation (the critical step)

Bilirubin is conjugated with glucuronic acid by bilirubin-UDP-glucuronosyltransferase (UGT1A1), located in the smooth endoplasmic reticulum. Each bilirubin molecule reacts with two UDP-glucuronic acid (UDPGA) molecules to form:
  • Bilirubin monoglucuronide (BMG) - intermediate
  • Bilirubin diglucuronide (BDG) - the predominant excreted form
Conjugation disrupts the internal hydrogen bonds, making the molecule water-soluble. This is obligatory for excretion into bile. The UGT1A1 gene is part of the UGT1 gene complex on chromosome 2; mutations in the shared exons (2-5) affect all UGT1 isoforms, while mutations in the substrate-specific first exon (A1) affect only UGT1A1 - the basis for Crigler-Najjar and Gilbert syndromes. - Harrison's 22E; Ganong's 26th Ed.

Step 4 - Biliary Excretion

BDG and BMG are actively transported across the canalicular membrane into bile by MRP2 (multidrug resistance-associated protein 2, ABCC2) - an ATP-dependent transporter. A portion of the conjugates is also transported back into the portal circulation via MRP3 and then reuptaken by OATP1B1/1B3 (the hepatocyte-portal cycling pathway implicated in Rotor syndrome). - Harrison's 22E

5. Intestinal Fate and Enterohepatic Circulation

Once conjugated bilirubin reaches the duodenum:
  • The intestinal mucosa is impermeable to conjugated bilirubin (so it does not get directly reabsorbed)
  • Gut bacteria (in the terminal ileum and colon) convert it to urobilinogens - a series of colorless, water-soluble compounds
  • ~10-20% of urobilinogens are reabsorbed into the portal circulation - this is the enterohepatic circulation of bilirubin
  • Most reabsorbed urobilinogen is re-excreted by the liver
  • A small amount reaches the systemic circulation and is excreted in the urine as urobilinogen
  • The oxidized form, urobilin (stercobilin), gives stool its brown color
In biliary obstruction, no bilirubin reaches the gut → stool becomes pale/clay-colored and urobilinogen disappears from urine. - Ganong's 26th Ed.; Harrison's 22E

6. Renal Handling

  • Unconjugated bilirubin: NOT excreted in urine (too tightly albumin-bound; no tubular secretion mechanism)
  • Conjugated bilirubin: Filtered at the glomerulus and excreted in urine → bilirubinuria (dark urine) is a sign of conjugated hyperbilirubinemia

7. Jaundice (Icterus)

Jaundice is the yellow discoloration of skin, sclera, and mucous membranes caused by bilirubin deposition. It becomes clinically detectable when total plasma bilirubin exceeds 2 mg/dL (34 μmol/L). The sclera is affected earliest due to its high elastin content, which has a high affinity for bilirubin. - Ganong's 26th Ed.

8. Classification of Jaundice

A. Pre-hepatic (Hemolytic) Jaundice

Mechanism: Excess bilirubin production overwhelms normal hepatic conjugation capacity.
Causes:
  • Hemolytic anemias (sickle cell, hereditary spherocytosis, G6PD deficiency, autoimmune hemolysis)
  • Ineffective erythropoiesis (thalassemia major, megaloblastic anemia, lead poisoning, dyserythropoietic anemias)
  • Massive tissue hematomas/infarctions
  • Transfusion reactions
Key features:
  • Predominantly unconjugated hyperbilirubinemia
  • Bilirubin rarely exceeds 4 mg/dL with normal liver function (the liver can increase conjugation 8-fold, but cannot exceed this indefinitely)
  • No bilirubinuria (unconjugated bilirubin is not filtered)
  • Increased urobilinogen in urine and stool
  • Pigment gallstones (bilirubin stones) may form with chronic hemolysis
  • Reticulocytosis, anemia, raised LDH, low haptoglobin
  • Harrison's 22E

B. Hepatic (Hepatocellular) Jaundice

Mechanism: Damaged hepatocytes fail to take up, conjugate, or excrete bilirubin efficiently. Usually produces mixed (both conjugated and unconjugated) hyperbilirubinemia.
Causes:
  • Acute viral hepatitis (A, B, C, E)
  • Alcoholic hepatitis
  • Drug-induced liver injury (acetaminophen, isoniazid, etc.)
  • Autoimmune hepatitis
  • Cirrhosis
  • Leptospirosis, sepsis
Key features:
  • Mixed hyperbilirubinemia - both direct and indirect elevated
  • Bilirubinuria present (conjugated fraction filters)
  • Reduced urobilinogen (liver cannot re-excrete it from the portal blood)
  • Raised transaminases (AST, ALT) markedly elevated
  • Abnormal liver function tests (PT, albumin)
Inherited hepatocellular disorders are classified separately:
ConditionDefectBilirubin TypeFeatures
Gilbert SyndromeReduced UGT1A1 expression (A[TA]₇TAA promoter polymorphism) + mildly reduced uptakeUnconjugatedBenign, intermittent, triggered by fasting/stress; prevalence ~5-10%
Crigler-Najjar Type I (CN-I)Complete absence of UGT1A1Severe unconjugatedLife-threatening; kernicterus without phototherapy/transplant
Crigler-Najjar Type II (CN-II)Severely reduced UGT1A1 (<10% of normal)UnconjugatedLess severe; responds to phenobarbital
Dubin-Johnson Syndrome (DJS)Absent MRP2 (ABCC2) - defective canalicular excretionPredominantly conjugatedBenign; black liver pigment; typical BSP excretion pattern; worsened by pregnancy/OCPs
Rotor SyndromeAbsent OATP1B1 + OATP1B3 - defective hepatic reuptake of secreted conjugatesPredominantly conjugatedBenign; normal liver histology; no pigment deposits
  • Harrison's 22E

C. Post-hepatic (Obstructive/Cholestatic) Jaundice

Mechanism: Mechanical obstruction to bile flow causes conjugated bilirubin to regurgitate back into the bloodstream.
Causes:
  • Intrahepatic cholestasis: Primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), intrahepatic cholestasis of pregnancy, drug-induced cholestasis, TPN-associated cholestasis
  • Extrahepatic obstruction: Choledocholithiasis (CBD stones), carcinoma of the head of pancreas, cholangiocarcinoma, ampullary carcinoma, biliary strictures, pancreatitis, lymph node compression
Key features:
  • Predominantly conjugated hyperbilirubinemia
  • Dark urine (bilirubinuria) - conjugated bilirubin is water-soluble and renally excreted
  • Pale/clay-colored stools - no bilirubin reaching the gut
  • No urobilinogen in urine or stool
  • Pruritus - bile salts deposited in skin
  • Raised alkaline phosphatase (ALP) and GGT - markers of biliary obstruction (much greater rise than in hepatocellular disease)
  • Steatorrhea - fat malabsorption due to lack of bile salts
  • Fat-soluble vitamin deficiency (A, D, E, K) - vitamin K deficiency causes coagulopathy
  • Dilated bile ducts on imaging
  • Ganong's 26th Ed.; Schwartz's Principles of Surgery, 11th Ed.

9. Neonatal (Physiological) Jaundice

A special category: most neonates develop mild unconjugated hyperbilirubinemia in the first week of life because:
  • Low UGT1A1 activity at birth
  • Underdeveloped intestinal flora - bacteria that convert bilirubin to urobilinogen are absent, so unconjugated bilirubin undergoes enterohepatic recirculation
  • Higher RBC turnover in newborns
The condition is normally self-limiting. Severe cases (>20 mg/dL in term infants) risk kernicterus (bilirubin deposition in the basal ganglia). Treatment is with phototherapy (blue light isomerizes unconjugated bilirubin to a water-soluble form) or exchange transfusion. - Harrison's 22E

10. Quick Differential Summary

FeaturePre-hepaticHepaticPost-hepatic
Bilirubin typeUnconjugatedMixedConjugated
Urine bilirubinAbsentPresentPresent
Urine urobilinogenIncreasedDecreasedAbsent
Stool colorNormal/darkNormal/palePale (clay)
ALP / GGTNormalMildly raisedMarkedly raised
ALT / ASTNormalMarkedly raisedMildly raised
PruritusNoVariableYes
Sources:
  • Harrison's Principles of Internal Medicine, 22E (2025), Chap. 349
  • Ganong's Review of Medical Physiology, 26th Ed., Chap. 28
  • Schwartz's Principles of Surgery, 11th Ed., Chap. 15

Generate a clinical summary PDF on diagnosing jaundice with decision trees

Reading File
Running Command
Running Command
Writing File
Running Command
Editing File
Running Command
Running Command
Your PDF is ready:

Diagnosing Jaundice Clinical Summary

PDF Document · PDF

Here's what's inside the 4-page clinical summary:
Page 1 - Bilirubin Metabolism
  • Definition of jaundice with clinical detection threshold
  • 8-step metabolism table: heme oxygenase → biliverdin reductase → albumin transport → OATP uptake → GST binding → UGT1A1 conjugation → MRP2 excretion → enterohepatic circulation
Page 2 - Main Diagnostic Decision Tree
  • Visual tree starting from "Patient presents with jaundice," branching on conjugated vs unconjugated bilirubin, then into 4 leaf categories (pre-hepatic, inherited unconjugated, hepatocellular, post-hepatic)
  • Color-coded urine/stool/lab pattern summary panel (ALP, GGT, AST, ALT across all three types)
Page 3 - Detailed Comparison + Inherited Syndromes
  • 13-row comparison table across pre-hepatic, hepatocellular, and post-hepatic jaundice (mechanism, bilirubin type, urine, stool, enzymes, investigations, causes)
  • Inherited disorders table: Gilbert, Crigler-Najjar I/II, Dubin-Johnson, Rotor syndromes with defects, levels, features, and treatment
Page 4 - Cholestasis Tree + Investigations + Red Flags
  • Second decision tree: conjugated hyperbilirubinemia → ultrasound → intrahepatic vs extrahepatic differential with specific diagnoses
  • Step-wise investigations guide (1st line → viral serology → haemolysis workup → obstructive imaging)
  • 8 red flag features with urgency labels (Charcot's triad, Reynolds' pentad, Courvoisier's sign, etc.)
  • Special population notes (neonates, pregnancy, HIV, elderly)
This is a shared conversation. Sign in to Orris to start your own chat.